On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa
Country advances with historic law and regulations that can transform agriculture, economy, and environment
Pharmacy student at Unifesp reveals, in a study, that cannabis can alleviate symptoms and improve the quality of life of patients with autoimmune diseases
The new law provides for medical training, patient regulation, and guarantee of access to cannabis-derived products in the municipal health system
Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan
Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD
Public hearing will present a balance of the first year of cannabis in the São Paulo public health system and will encourage projects in science, innovation, and social impact
Experts point out that the US experience can accelerate national development
Partnership strengthens the brand and boosts awareness actions on medical cannabis in Germany
According to Clayton Medeiros, access to health should not depend on habeas corpus, but on clear and inclusive public policies
Proposal from the European Commission paves the way for full regulation of hemp and strengthening of the non-psychoactive cannabis market
The President emphasized the responsibility of the appointees and reinforced the importance of the agencies for the country's development
Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics
Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics
Understand how the substance can influence appetite, anxiety, and mood, and what essential medical care is needed
Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition
South African researchers identify rare phenolic compounds, flavoalkaloids, in cannabis leaves for the first time, revealing new medicinal potential of the plant
Advancements in automation, artificial intelligence, and blockchain are transforming how producers optimize yields, reduce costs, and ensure quality
Study indicates that medicinal cannabis shows promising results in the treatment of orofacial pain in Dentistry, but further studies on safety and clinical application are still needed
Proposal aims to transform seized cannabis into input for research and medications
First placebo-controlled study shows that vaporized cannabis, especially the THC/CBD combination, can reduce pain and symptoms of acute migraine in just a few hours
Experts point out that federal legalization could open doors for national trademarks, but obstacles still persist
The event brought together students and professionals who see the event as a unique opportunity for exchange, scientific updating, and connection with the future of medicine
Regulatory advances expand access to cannabis treatments for animals, but veterinarians still face barriers in prescribing and regulating products
The study included clinical trials with adults with major depressive disorder (MDD) or treatment-resistant depression (TRD)
The oncologic pain market is expected to grow from $6.53 billion in 2024 to $11.81 billion by 2034, driven by opioids, non-opioids, and medicinal cannabis as a promising alternative in relieving pain for cancer patients
Deusa Cast #43 discusses the paths of cannabis: human, pets, and construction industry.
Google launches pilot program in Canada allowing licensed cannabis companies to advertise on Search
Unprecedented partnership aims to combine science, innovation, and regulation to turn hemp into a new frontier of Brazilian agribusiness
The cannabis-based cosmetics market is expected to grow from $5.48 billion in 2024 to $22.43 billion in 2029, driven by natural, sustainable, and innovative products focused on wellness and skincare